FMT
TCRR

First Mercantile Trust’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

First Mercantile Trust’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$28K Hold
3,292
– – ﹤0.01% 810
2021
Q2 		$54K Buy
3,292
+325
+11% +$6.57K 0.01% 790
2021
Q1 		$66K Sell
2,967
-500
-14% -$13.6K 0.01% 755
2020
Q4 		$107K Buy
+3,467
New +$87.7K 0.01% 672

Other funds holding TCRR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

First Mercantile Trust's TCRR Position: Q3 2021 in Review

First Mercantile Trust held its TCR2 Therapeutics Inc. Common Stock (TCRR) position steady in Q3 2021 at 3,292 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

First Mercantile Trust first reported a position in TCRR in Q4 2020 and has held it in 4 quarters since. The position peaked at $107K in Q4 2020. 117 funds tracked by Wall St. Rank hold TCRR as of Q3 2021.

  • First Mercantile Trust held 3,292 shares of TCR2 Therapeutics Inc. Common Stock worth $28K as of Q3 2021.
  • First Mercantile Trust left its TCR2 Therapeutics Inc. Common Stock share count unchanged in Q3 2021.
  • TCR2 Therapeutics Inc. Common Stock made up ﹤0.01% of First Mercantile Trust's portfolio in Q3 2021, its #810 holding.
  • First Mercantile Trust first reported a position in TCR2 Therapeutics Inc. Common Stock in Q4 2020 and has held it in 4 quarters since.
  • First Mercantile Trust's TCR2 Therapeutics Inc. Common Stock position peaked at $107K in Q4 2020.
  • 117 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.